Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene

Circulation

Volumn 97, Issue 9, 1998, Pages 871-877

  Gaudet, Daniel ^a,b   Vohl, Marie Claude ^b   Perron, Patrice ^a   Tremblay, Gérald ^a   Gagné, Claude ^a,b   Lesiège, Daniel ^a   Bergeron, Jean ^b   Moorjani, Sital ^b   Després, Jean Pierre ^b  

^a CHICOUTIMI HOSPITAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Coronary disease; Hypercholesterolemia; Hyperinsulinemia; Obesity

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ANTHROPOMETRY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HETEROZYGOTE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0032502260     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.9.871     Document Type: Article

References (53)

1. Lowel H, Dobson A, Keil U, Herman B, Hobbs MST, Stewart A, Arstila M, Miettinen H, Mustaniemi H, Tuomilehto J. Coronary heart disease case fatality in four countries: a community study. Circulation. 1993;88: 2524-2531.
2. Yusuf S, Anand S. Cost of prevention: the case of lipid lowering. Circulation. 1996;15:1796-1802.
3. Beaglehole R. International trends in coronary heart disease mortality, morbidity, and risk factors. Epidemiol Rev. 1990;12:1-15.
4. Levy D, Wilson PW, Anderson KM, Castelli PW. Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J. 1990;119:712-717.
5. Assmann G, Frick MH. Redefining risk factors for coronary heart disease: the benefit of regulating lipoproteins. Drugs. 1990;40:1-56.
6. The Lipid Research Clinics Coronary Primary Prevention Trial results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365-374.
7. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
8. Hill JS, Hayden MR, Frohlich J, Pritchard PH. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb. 1991;11:290-297.
9. Kotze MJ, Davis HJ, Bissbort S, Langenhoven E, Brusnicky J, Oosthuizen CJ. Intrafamilial variability in the clinical expression of familial hypercholesterolemia: importance of risk factor determination for genetic counselling. Clin Genet. 1993;43:295-299.
10. Roy M, Sing CF, Betard C, Davignon J. Impact of a common mutation of the LDL receptor gene in French-Canadian patients with familial hypercholesterolemia, on means, variances and correlations among traits of lipid metabolism. Clin Genet. 1995;47:59-67.
11. Kissebah AH, Peiris AN, Evans DJ. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 1989;5:83-109.
12. Björntorp P. Abdominal obesity and the development of non-insulin dependent diabetes mellitus. Diabetes Metab Rev. 1988;4:615-622.
13. Björntorp P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990;10:493-496.
14. Avellone G, Di Garbo V, Cordova R, Rotolo G, Abruzzese G, Raneli G. De Simone R, Bompiani GD. Blood coagulation and fibrinolysis in obese NIDDM patients. Diabetes Res. 1994;25:85-92.
15. Després JP. Obesity and lipid metabolism: relevance of body fat distribution. Curr Opin Lipidol. 1991;2:5-115.
16. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497-511.
17. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ. Waist circumference and abdominal sagittal indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-468.
18. Casassus P, Fontbonne A, Thibult N, Ducimetiere P, Richard JL, Claude JR, Warnet JM, Rosselin G, Eschwege E. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality - the Paris Prospective Study. Arterioscler Thromb. 1992;12:1387-1392.
19. Després JP, Lamarche B, Meurig P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-975.
20. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
21. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation. 1997;95:1-4.
22. Lander SE, Shork NJ. Genetic dissection of complex traits. Science. 1994; 265:2037-2048.
23. Gaudet D, Moorjani S. Gagné C, Julien P, Tremblay G, Perron P, Després JP, Lupien PJ. Premature coronary artery disease and high prevalence of monogenic traits for lipid disorders among French Canadians in North Eastern region of Quebec province. Atherosclerosis. 1994;109:131. Abstract.
24. Gaudet D, Tremblay G, Perron P, Gagné C, Ouadahi Y, Moorjani S. Familial hypercholesterolemia in Eastern Quebec: is it a public health issue? Union Med Can. 1995;124:54-60.
25. Vohl MC, Couture P, Moorjani S, Torres AL, Gagné C, Després JP, Lupien PJ, Labrie F, Simard J. Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French Canadians. Hum Mutat. 1995;6:243-246.
26. Ma Y, Bétard C, Roy M, Davignon J, Kessling AM. Identification of a second French Canadian LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin Genet. 1989;36:219-228.
27. Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH. Common low density lipoprotein receptor mutations in French Canadian population. J Clin Invest. 1990;85:1014-1023.
28. Standardization of anthropometric measurements. In: Lohman T, Roche A, Martorel R, eds. The Airlie (VA) Consensus Conference. Champaign, Ill, Human Kinetics Publishers. 1988:39-80.
29. Richterich R, Dauwalder H. Zur bestimmung der plasmaglukose-konzentration mit der hexokinase-glucose-6-phosphat-dehydroghenase-method. Schweiz Med Wochenschr. 1971;101:615-618.
30. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.J Clin Endocrinol Metab. 1971;37:732-738.
31. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
32. Burstein M, Samaille J. Quick dosage of cholesterol linked to plasma alpha-and beta-lipoproteins. Clin Chim Acta. 1960;5:609-610.
33. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta. 1987;166:1-8.
34. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem. 1982;28:1379-1387.
35. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
36. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966;15:45-52.
37. Moorjani S, Roy M, Bétard C, Torres A, Gagné C, Lambert M, Brun D, Davignon J, Lupien PJ. Variation in plasma cholesterol and expression of coronary heart disease in homozygous familial hypercholesterolemia based on low density lipoprotein receptor gene mutations. Lancet. 1993;341: 1303-1306.
38. Williams RR, Hasstedt SJ, Wilson DE, Ash KO, Yanowitz FF, Reiber GE, Kuida H. Evidence that men with familial hypercholesterolemia can avoid early coronary death: an analysis of 77 gene carriers in four Utah pedigrees. JAMA. 1986;255:219-224.
39. Vohl MC, Gaudet D, Moorjani S, Tremblay G, Perron P, Gagné C, Lesiège D, Bergeron J, Lupien PJ, Després JP. Comparison of the effect of two low-density-lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygotes for familial hypercholesterolemia. Eur J Clin Invest. 1997;27:366-373.
40. Carmelli D, Cardo, LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environment? Am J Hum Genet. 1994;55:566-573.
41. Allemann Y, Horber FF, Colombo M, Ferrari P, Shaw S, Jaeger P, Weidmann P. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet. 1993;341:327-331.
42. Hopkins PN, Hunt SC, Wu LL, Williams GH, Williams RR. Hypertension, dyslipidemia and insulin resistance: links in a chain or spokes on a wheel? Curr Opin Lipidol. 1996;7:241-253.
43. Moorjani S, Gagné C, Lupien PJ, Brun D. Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. Metabolism. 1986;35:311-316.
44. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després J-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Circulation. 1997;95:69-75.
45. Austin MA. Plasma triglyceride and coronary heart disease. Anerioscler Thromb. 1991;11:2-14.
46. Stern MP. Perspectives in diabetes, diabetes and cardiovascular disease, the common soil hypothesis. Diabetes. 1995;44:369-374.
47. Kwiterovitch PO, Coresh J, Bachorik PS. Prevalence of hyperbeta lipoproteinemia and other lipoprotein phenotypes in men (aged <50 years) and women (aged <60 years) with coronary artery disease. Am J Cardiol. 1993;71:631-639.
48. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study). Am J Cardiol. 1995;75:1189-1195.
49. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human low density (β) lipoproteins). Proc Natl Acad Sci U S A. 1980;77:604-608.
50. Lamarche B, Després JP, Pouliot MC, Prud'homme D, Moorjani S, Lupien PJ, Nadeau A, Tremblay A, Bouchard C. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Anerioscler Thromb. 1993;13:33-40.
51. Schaefer EJ, Levy RI, Anderson D, Danner RN, Brewer HB Jr, Blackwelder WC. Plasma triglycerides in regulation of HDL cholesterol levels. Lancet. 1978;2:391-393.
52. Patsch JR, Miesenbock K, Hopferweiser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsh W. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb. 1992;12:1336-1345.
53. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137:959-965.